HIV-associated nemaline rod myopathy: Role of intravenous immunoglobulin therapy in two persons with HIV/AIDS

AIDS Reader

Volumn 18, Issue 2, 2008, Pages 90-94

  De Sanctis, Jorgelina T ^a   Cumbo Nacheli, Gustavo ^b   Dobbie, David ^c   Baumgartner, David ^d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d Saint Mary's Health Care   (United States)

Author keywords

HIV AIDS; Immunoglobulin therapy; Myopathy

Indexed keywords

EFAVIRENZ; EMTRICITABINE; IMMUNOGLOBULIN; LAMIVUDINE; PREDNISONE; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NEMALINE MYOPATHY; SYMPTOM;

HIV INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOPATHIES, NEMALINE; TREATMENT OUTCOME;

EID: 39049096839     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Schnell C, Kan A, North KN. "An artefact gone awry": identification of the first case of nemaline myopathy by Dr R.D.K. Reye. Neuromuscul Disord. 2000; 10:307-312.
2. Shy GM, Engel WK, Somers JE, Wanko T. Nemaline myopathy. A new congenital myopathy. Brain. 1963;86:793-810.
3. Conen PE, Murphy EG, Donohue WL. Light and electron microscopic studies of "myogranules" in a child with hypotonia and muscle weakness. Can Med Assoc J. 1963;89:983-986.
4. Chahin N, Selcen D, Engel AG. Sporadic late onset nemaline myopathy. Neurology. 2005;65:1158-1164.
5. Miro O, Grau JM, Pedrol E. Distinct light microscopic changes in HIV-associated nemaline myopathy. Neurology. 1999;53:239.
6. Dalakas MC, Pezeshkpour GH, Flaherty M. Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med. 1987;317:1602-1603.
7. Maytal J, Horowitz S, Lipper S, et al. Progressive nemaline rod myopathy in a woman coinfected with HIV-1 and HTLV-2. Mt Sinai J Med. 1993;60:242-246.
8. Fontana L, Castro C, Mullen M. Intravenous gammaglobulin in the prevention of infections in severely immunocompromised AIDS patients. 1997 International Scientific Assembly of the American College of Chest Physicians; 1997; New Orleans. Abstract 14S.
9. Colmegna I, Koehler JW, Garry RF, Espinoza LR. Musculoskeletal and autoimmune manifestations of HIV, syphilis and tuberculosis. Curr Opin Rheumatol. 2006;18:88-95.
10. Sheikh RA, Yasmeen S, Munn R, et al. AIDS-related myopathy. Med Electron Microsc. 1999;32:79-86.
11. Cabello A, Martinez-Martin P, Gutierrez-Rivas E, Madero S. Myopathy with nemaline structures associated with HIV infection. J Neurol. 1990;237:64-65.
12. Ginanneschi F, Mondelli M, Malandrini A, et al. Nemaline myopathy: description of an adult onset case. J Submicrosc Cytol Pathol. 2002;34:105-108.
13. Keller CE, Hays AP, Rowland LP, et al. Adult-onset nemaline myopathy and monoclonal gammopathy. Arch Neurol. 2006;63:132-134.
14. Pavlu J, Carey MP, Winer JB. Hypothyroidism and nemaline myopathy in an adult. J Neurol Neurosurg Psychiatry. 2006;77:708-709.
15. Kiernan MC, Bullpitt P, Chan JH. Mitochondrial dysfunction and rod-like lesions associated with administration of beta-2 adrenoceptor agonist formoterol. Neuromuscul Disord. 2004;14:375-377.
16. Portlock CS, Boland P, Hays AP, et al. Nemaline myopathy: a possible late complication of Hodgkin's disease therapy. Hum Pathol. 2003;34:816-818.
17. North KN, Laing NG, Wallgren-Pettersson C. Nemaline myopathy: current concepts. The ENMC International Consortium and Nemaline Myopathy. J Med Genet. 1997;34:705-713.
18. Eymard B, Brouet JC, Collin H, et al. Late-onset rod myopathy associated with monoclonal gammopathy. Neuromuscul Disord. 1993;3:557-560.
19. Anderson SL, Ekstein J, Donnelly MC, et al. Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene. Hum Genet. 2004;115:185-190.
20. Bruno C, Minetti C. Congenital myopathies. Current Neurol Neurosci Rep. 2004,4:68-73.
21. Sharma MC, Gulati S, Atri S, et al. Nemaline rod myopathy: a rare form of myopathy. Neurol India. 2007;55:70-74.
22. Pelin K, Hilpela P, Dormer K, et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci U S A. 1999;96:2305-2310.
23. Schroder JM, Durling H, Laing N. Actin myopathy with nemaline bodies, intranuclear rods, and a heterozygous mutation in ACTA1 (Asp154Asn). Acta Neuropathol (Berl). 2004;108:250-256.
24. Corbett MA, Akkari PA, Domazetovska A, et al. An alpha-tropomyosin mutation alters dimer preference in nemaline myopathy. Ann Neurol. 2005;57: 42-49.
25. Ryan MM, Schnell C, Strickland CD, et al. Nemaline myopathy: a clinical study of 143 cases. Ann Neurol. 2001;50:312-320.
26. Ilkovski B, Cooper ST, Nowak K, et al. Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet. 2001;68:1333-1343.
27. Botelho CH, Carod-Artal FJ, Kalil RK. Nemaline congenital myopathy: clinical features and histopathological findings in nine patients. Rev Neurol. 2001;32:309-314.
28. Nonaka I, Ishiura S, Arahata K, et al. Progression in nemaline myopathy. Acta Neuropathol (Berl). 1989; 78:484-491.
29. Miro O, Masanes F, Pedrol E, et al. A comparative study of the clinical and histological characteristics between classic nemaline myopathy and that associated with the human immunodeficiency virus. Med Clin (Barc). 1995;105:500-503.
30. Huang CC, Lee CC, Chen SS. Fiber type disproportion in nemaline myopathy. Zhonghua Yi Xue Za Zhi. 1989;43:229-232.
31. Gyure KA, Prayson RA, Estes ML. Adult-onset nemaline myopathy: a case report and review of the literature. Arch Pathol Lab Med. 1997;121:1210-1213.
32. Feinberg DM, Spiro AJ, Weidenheim KM. Distinct light microscopic changes in human immunodeficiency virus-associated nemaline myopathy. Neurology. 1998;50:529-531.
33. Shimomura C, Nonaka I. Nemaline myopathy: comparative muscle histochemistry in the severe neonatal, moderate congenital, and adult-onset forms. Pediatr Neurol. 1990;6:66.
34. Ryan MM, Ilkovski B, Strickland CD, et al. Clinical course correlates poorly with muscle pathology in nemaline myopathy. Neurology. 2003;60:665-673.
35. Faingold R, Oudjhane K, Armstrong DC, Albuquerque PA. Magnetic resonance imaging of congenital, inflammatory, and infectious soft-tissue lesions in children. Top Magn Reson Imaging. 2002;13: 241-261.
36. Scott DL, Kingsley GH. Use of imaging to assess patients with muscle disease. Curr Opin Rheumatol 2004;16:678-683.
37. Mercuri E, Jungbluth H, Muntoni F. Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol. 2005;18:526-537.
38. Lampa J, Nennesmo I, Einarsdottir H, Lundberg I. MRI guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease. Ann Rheum Dis. 2001;60:423-426.
39. Sekul EA, Chow C, Dalakas MC. Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis. Neurology. 1997;48:863-866.
40. Jungbluth H, Sewry CA, Counsell S, et al. Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord. 2004;14:779-784.
41. Dwyer BA, Mayer RF, Lee SC. Progressive nemaline (rod) myopathy as a presentation of human immunodeficiency virus infection. Arch Neurol. 1992;49: 440.
42. Deconinck N, Laterre EC, Van den Bergh PY. Adult-onset nemaline myopathy and monoclonal gammopathy: a case report. Acta Neurol Belg. 2000; 100:34-40.
43. Bayry J, Thirion M, Misra N, et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci. 2003; 24(suppl4):S217-S221.
44. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med. 2001; 345:747-755.
45. Authier FJ, Chariot P, Gherardi RK. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve. 2005;32: 247-260.